Report — Sanofi close to bagging Flexion in a looming $1B-plus buyout, shares rocket up
Sanofi has struck a deal to buy Flexion $FLXN and the pain drug it now has under review at the FDA, according to a scoop …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
